1、Priyadarsini S, Whelchel A, Nicholas S, et al. Diabetic keratopathy: Insights and challenges[J]. Surv Ophthalmol, 2020, 65(5): 513-529.Priyadarsini S, Whelchel A, Nicholas S, et al. Diabetic keratopathy: Insights and challenges[J]. Surv Ophthalmol, 2020, 65(5): 513-529.
2、许文进, 李兵. II型糖尿病的发病机制与治疗[ J]. 医药卫生(文摘版), 2017, 8(1): 00106.
XU Wenjin, LI Bing. Pathogenesis and treatment of type 2 diabetes mellitus[ J]. Medicine and Health, 2017, 8(1): 00106.许文进, 李兵. II型糖尿病的发病机制与治疗[ J]. 医药卫生(文摘版), 2017, 8(1): 00106.
XU Wenjin, LI Bing. Pathogenesis and treatment of type 2 diabetes mellitus[ J]. Medicine and Health, 2017, 8(1): 00106.
3、但婧, 周庆军, 谢立信. 晚期糖基化终末产物与糖尿病角膜病变
关系的研究进展[ J]. 中华眼科杂志, 2018, 54(6): 475-480.
DAN Jing, ZHOU Qingjun, XIE Lixin. The research progress of
relationship between advanced glycation end products and diabetic
keratopathy[ J]. Chinese Journal of Ophthalmology, 2018, 54(6):
475-480.但婧, 周庆军, 谢立信. 晚期糖基化终末产物与糖尿病角膜病变
关系的研究进展[ J]. 中华眼科杂志, 2018, 54(6): 475-480.
DAN Jing, ZHOU Qingjun, XIE Lixin. The research progress of
relationship between advanced glycation end products and diabetic
keratopathy[ J]. Chinese Journal of Ophthalmology, 2018, 54(6):
475-480.
4、高艳. AGEs/AGER1/Sirt1通路在糖尿病角膜病变中的作用及机
制研究[D]. 青岛: 青岛大学, 2016.
GAO Yan. The role and mechanism of AGEs/AGER1/Sirt1 pathway in
diabetic keratopathy[D]. Qingdao: Qingdao University, 2016.高艳. AGEs/AGER1/Sirt1通路在糖尿病角膜病变中的作用及机
制研究[D]. 青岛: 青岛大学, 2016.
GAO Yan. The role and mechanism of AGEs/AGER1/Sirt1 pathway in
diabetic keratopathy[D]. Qingdao: Qingdao University, 2016.
5、American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1): S13-S28.American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019[J]. Diabetes Care, 2019, 42(Suppl 1): S13-S28.
6、Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes[J]. Diabetes Res Clin Pract, 2014, 105(2): 141-150.Esser N, Legrand-Poels S, Piette J, et al. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes[J]. Diabetes Res Clin Pract, 2014, 105(2): 141-150.
7、Basile KJ, Johnson ME, Xia Q, et al. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies[J]. Int J Endocrinol, 2014, 2014: 769671.Basile KJ, Johnson ME, Xia Q, et al. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies[J]. Int J Endocrinol, 2014, 2014: 769671.
8、Markoulli M, Flanagan J, Tummanapalli SS, et al. The impact of diabetes on corneal nerve morphology and ocular surface integrity[J]. Ocul Surf, 2018, 16(1): 45-57.Markoulli M, Flanagan J, Tummanapalli SS, et al. The impact of diabetes on corneal nerve morphology and ocular surface integrity[J]. Ocul Surf, 2018, 16(1): 45-57.
9、Zhao H, He Y, Ren YR, et al. Corneal alteration and pathogenesis in diabetes mellitus[J]. Int J Ophthalmol, 2019, 12(12): 1939-1950.Zhao H, He Y, Ren YR, et al. Corneal alteration and pathogenesis in diabetes mellitus[J]. Int J Ophthalmol, 2019, 12(12): 1939-1950.
10、Miller DD, Hasan SA, Simmons NL, et al. Recurrent corneal erosion: a comprehensive review[J]. Clin Ophthalmol, 2019, 13: 325-335.Miller DD, Hasan SA, Simmons NL, et al. Recurrent corneal erosion: a comprehensive review[J]. Clin Ophthalmol, 2019, 13: 325-335.
11、Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms[J]. Lab Invest, 1995, 72(4): 461-473.Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Human corneal basement membrane heterogeneity: topographical differences in the expression of type IV collagen and laminin isoforms[J]. Lab Invest, 1995, 72(4): 461-473.
12、Chang PY, Carrel H, Huang JS, et al. Decreased density of corneal basal epithelium and subbasal corneal nerve bundle changes in patients with diabetic retinopathy[J]. Am J Ophthalmol, 2006, 142(3): 488-490.Chang PY, Carrel H, Huang JS, et al. Decreased density of corneal basal epithelium and subbasal corneal nerve bundle changes in patients with diabetic retinopathy[J]. Am J Ophthalmol, 2006, 142(3): 488-490.
13、Müller LJ, Marfurt CF, Kruse F, et al. Corneal nerves: structure, contents and function[J]. Exp Eye Res, 2003, 76(5): 521-542.Müller LJ, Marfurt CF, Kruse F, et al. Corneal nerves: structure, contents and function[J]. Exp Eye Res, 2003, 76(5): 521-542.
14、Byun YS, Kang B, Yoo YS, et al. Poly(ADP-Ribose) polymerase inhibition improves corneal epithelial innervation and wound healing in diabetic rats[J]. Invest Ophthalmol Vis Sci, 2015, 56(3): 1948-1955.Byun YS, Kang B, Yoo YS, et al. Poly(ADP-Ribose) polymerase inhibition improves corneal epithelial innervation and wound healing in diabetic rats[J]. Invest Ophthalmol Vis Sci, 2015, 56(3): 1948-1955.
15、陈奔, 李雅嘉, 王华, 等. 生长因子在糖尿病角膜病变的作用[ J].
临床与病理杂志, 2016, 36(9): 1457-1462.
CHEN Ben, LI Yajia, WANG Hua, et al. Role of growth factor in
diabetic keratopathy[ J]. Journal of Clinical and Pathology Research,
2016, 36(9): 1457-1462.陈奔, 李雅嘉, 王华, 等. 生长因子在糖尿病角膜病变的作用[ J].
临床与病理杂志, 2016, 36(9): 1457-1462.
CHEN Ben, LI Yajia, WANG Hua, et al. Role of growth factor in
diabetic keratopathy[ J]. Journal of Clinical and Pathology Research,
2016, 36(9): 1457-1462.
16、Al-Aqaba MA, Dhillon VK, Mohammed I, et al. Corneal nerves in health and disease[J]. Prog Retin Eye Res, 2019, 73: 100762.Al-Aqaba MA, Dhillon VK, Mohammed I, et al. Corneal nerves in health and disease[J]. Prog Retin Eye Res, 2019, 73: 100762.
17、Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes[J]. Invest Ophthalmol Vis Sci, 1981, 20(4): 548-553.Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes[J]. Invest Ophthalmol Vis Sci, 1981, 20(4): 548-553.
18、Ishida M, Yokoi N, Okuzawa J, et al. Corneal autofluorescence in patients with diabetic retinopathy[J]. Nippon Ganka Gakkai Zasshi, 1995, 99(3): 308-311.Ishida M, Yokoi N, Okuzawa J, et al. Corneal autofluorescence in patients with diabetic retinopathy[J]. Nippon Ganka Gakkai Zasshi, 1995, 99(3): 308-311.
19、Mishima S. Clinical investigations on the corneal endothelium[J]. Ophthalmology, 1982, 89(6): 525-530.Mishima S. Clinical investigations on the corneal endothelium[J]. Ophthalmology, 1982, 89(6): 525-530.
20、Shi L, Yu X, Yang H, et al. Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways[J]. PLoS One, 2013, 8(6): e66781.Shi L, Yu X, Yang H, et al. Advanced glycation end products induce human corneal epithelial cells apoptosis through generation of reactive oxygen species and activation of JNK and p38 MAPK pathways[J]. PLoS One, 2013, 8(6): e66781.
21、Vieira-Potter VJ, Karamichos D, Lee DJ. Ocular complications of diabetes and therapeutic approaches[J]. Biomed Res Int, 2016, 2016: 3801570.Vieira-Potter VJ, Karamichos D, Lee DJ. Ocular complications of diabetes and therapeutic approaches[J]. Biomed Res Int, 2016, 2016: 3801570.
22、Torricelli AA, Wilson SE. Cellular and extracellular matrix modulation of corneal stromal opacity[J]. Exp Eye Res, 2014, 129: 151-160.Torricelli AA, Wilson SE. Cellular and extracellular matrix modulation of corneal stromal opacity[J]. Exp Eye Res, 2014, 129: 151-160.
23、Zou C, Wang S, Huang F, et al. Advanced glycation end products and ultrastructural changes in corneas of long-term streptozotocin-induced diabetic monkeys[J]. Cornea, 2012, 31(12): 1455-1459.Zou C, Wang S, Huang F, et al. Advanced glycation end products and ultrastructural changes in corneas of long-term streptozotocin-induced diabetic monkeys[J]. Cornea, 2012, 31(12): 1455-1459.
24、Liaboe CA, Aldrich BT, Carter PC, et al. Assessing the impact of diabetes mellitus on donor corneal endothelial cell density[J]. Cornea, 2017, 36(5): 561-566.Liaboe CA, Aldrich BT, Carter PC, et al. Assessing the impact of diabetes mellitus on donor corneal endothelial cell density[J]. Cornea, 2017, 36(5): 561-566.
25、El-Agamy A, Alsubaie S. Corneal endothelium and central corneal thickness changes in type 2 diabetes mellitus[J]. Clin Ophthalmol, 2017, 11: 481-486.El-Agamy A, Alsubaie S. Corneal endothelium and central corneal thickness changes in type 2 diabetes mellitus[J]. Clin Ophthalmol, 2017, 11: 481-486.
26、Chen H, Zhang X, Liao N, et al. Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy[J]. BMC Ophthalmol, 2017, 17(1): 176.Chen H, Zhang X, Liao N, et al. Assessment of biomarkers using multiplex assays in aqueous humor of patients with diabetic retinopathy[J]. BMC Ophthalmol, 2017, 17(1): 176.
27、Emoto I, Beuerman RW. Stimulation of neurite growth by epithelial implants into corneal stroma[J]. Neurosci Lett, 1987, 82(2): 140-144.Emoto I, Beuerman RW. Stimulation of neurite growth by epithelial implants into corneal stroma[J]. Neurosci Lett, 1987, 82(2): 140-144.
28、Chen J, Chen P, Backman LJ, et al. Ciliary neurotrophic factor promotes the migration of corneal epithelial stem/progenitor cells by up-regulation of MMPs through the phosphorylation of Akt[J]. Sci Rep, 2016, 6: 25870.Chen J, Chen P, Backman LJ, et al. Ciliary neurotrophic factor promotes the migration of corneal epithelial stem/progenitor cells by up-regulation of MMPs through the phosphorylation of Akt[J]. Sci Rep, 2016, 6: 25870.
29、Ríos JD, Ghinelli E, Gu J, et al. Role of neurotrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation[J]. Invest Ophthalmol Vis Sci, 2007, 48(4): 1543-1551.Ríos JD, Ghinelli E, Gu J, et al. Role of neurotrophins and neurotrophin receptors in rat conjunctival goblet cell secretion and proliferation[J]. Invest Ophthalmol Vis Sci, 2007, 48(4): 1543-1551.
30、Di G, Qi X, Zhao X, et al. Corneal epithelium-derived neurotrophic factors promote nerve regeneration[J]. Invest Ophthalmol Vis Sci, 2017, 58(11): 4695-4702.Di G, Qi X, Zhao X, et al. Corneal epithelium-derived neurotrophic factors promote nerve regeneration[J]. Invest Ophthalmol Vis Sci, 2017, 58(11): 4695-4702.
31、Garcia-Hirschfeld J, Lopez-Briones LG, Belmonte C. Neurotrophic influences on corneal epithelial cells[J]. Exp Eye Res, 1994, 59(5): 597-605.Garcia-Hirschfeld J, Lopez-Briones LG, Belmonte C. Neurotrophic influences on corneal epithelial cells[J]. Exp Eye Res, 1994, 59(5): 597-605.
32、You L, Kruse FE, V?lcker HE. Neurotrophic factors in the human cornea[J]. Invest Ophthalmol Vis Sci, 2000, 41(3): 692-702.You L, Kruse FE, V?lcker HE. Neurotrophic factors in the human cornea[J]. Invest Ophthalmol Vis Sci, 2000, 41(3): 692-702.
33、Park JH, Kang SS, Kim JY, et al. Nerve growth factor attenuates apoptosis and inflammation in the diabetic cornea[J]. Invest Ophthalmol Vis Sci, 2016, 57(15): 6767-6775.Park JH, Kang SS, Kim JY, et al. Nerve growth factor attenuates apoptosis and inflammation in the diabetic cornea[J]. Invest Ophthalmol Vis Sci, 2016, 57(15): 6767-6775.
34、Apfel SC. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?[J]. Int Rev Neurobiol, 2002, 50: 393-413.Apfel SC. Nerve growth factor for the treatment of diabetic neuropathy: what went wrong, what went right, and what does the future hold?[J]. Int Rev Neurobiol, 2002, 50: 393-413.
35、Zagon IS, Klocek MS, Sassani JW, et al. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus[J]. Arch Ophthalmol, 2007, 125(8): 1082-1088.Zagon IS, Klocek MS, Sassani JW, et al. Use of topical insulin to normalize corneal epithelial healing in diabetes mellitus[J]. Arch Ophthalmol, 2007, 125(8): 1082-1088.
36、Vatankhah N, Jahangiri Y, Landry GJ, et al. Effect of systemic insulin treatment on diabetic wound healing[J]. Wound Repair Regen, 2017, 25(2): 288-291.Vatankhah N, Jahangiri Y, Landry GJ, et al. Effect of systemic insulin treatment on diabetic wound healing[J]. Wound Repair Regen, 2017, 25(2): 288-291.
37、Fai S, Ahem A, Mustapha M, et al. Randomized controlled trial of topical insulin for healing corneal epithelial defects induced during vitreoretinal surgery in diabetics[J]. Asia Pac J Ophthalmol (Phila), 2017, 6(5): 418-424.Fai S, Ahem A, Mustapha M, et al. Randomized controlled trial of topical insulin for healing corneal epithelial defects induced during vitreoretinal surgery in diabetics[J]. Asia Pac J Ophthalmol (Phila), 2017, 6(5): 418-424.
38、Ueno H, Hattori T, Kumagai Y, et al. Alterations in the corneal nerve and stem/progenitor cells in diabetes: preventive effects of insulin-like growth factor-1 treatment[J]. Int J Endocrinol, 2014, 2014: 312401.Ueno H, Hattori T, Kumagai Y, et al. Alterations in the corneal nerve and stem/progenitor cells in diabetes: preventive effects of insulin-like growth factor-1 treatment[J]. Int J Endocrinol, 2014, 2014: 312401.
39、Wu YC, Buckner BR, Zhu M, et al. Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium[J]. Ocul Surf, 2012, 10(2): 100-107.Wu YC, Buckner BR, Zhu M, et al. Elevated IGFBP3 levels in diabetic tears: a negative regulator of IGF-1 signaling in the corneal epithelium[J]. Ocul Surf, 2012, 10(2): 100-107.
40、Kubo E, Mori K, Kobayashi T, et al. Effect of aldose reductase inhibitor on corneal epithelial barrier function in galactose-fed dogs[J]. J Ocul Pharmacol Ther, 1998, 14(2): 181-190.Kubo E, Mori K, Kobayashi T, et al. Effect of aldose reductase inhibitor on corneal epithelial barrier function in galactose-fed dogs[J]. J Ocul Pharmacol Ther, 1998, 14(2): 181-190.
41、Zagon IS, Klocek MS, Sassani JW, et al. Corneal safety of topically applied naltrexone[J]. J Ocul Pharmacol Ther, 2006, 22(5): 377-387.Zagon IS, Klocek MS, Sassani JW, et al. Corneal safety of topically applied naltrexone[J]. J Ocul Pharmacol Ther, 2006, 22(5): 377-387.
42、Jacot JL, Hosotani H, Glover JP, et al. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors[J]. J Ocul Pharmacol Ther, 1998, 14(2): 169-180.Jacot JL, Hosotani H, Glover JP, et al. Diabetic-like corneal sensitivity loss in galactose-fed rats ameliorated with aldose reductase inhibitors[J]. J Ocul Pharmacol Ther, 1998, 14(2): 169-180.
43、刘文凤, 朱佩文, 邵毅. 线粒体功能障碍与角膜疾病研究进展[J]. 眼科新进展, 2019, 39(2): 197-200.刘文凤, 朱佩文, 邵毅. 线粒体功能障碍与角膜疾病研究进展[J]. 眼科新进展, 2019, 39(2): 197-200.
44、Recent advance of mitochondrial dysfunction and corneal diseases[J]. Recent Advances in Ophthalmology, 2019, 39(2): 197-200.Recent advance of mitochondrial dysfunction and corneal diseases[J]. Recent Advances in Ophthalmology, 2019, 39(2): 197-200.
45、Guo C, Li M, Qi X, et al. Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice[J]. Sci Rep, 2016, 6: 29753.Guo C, Li M, Qi X, et al. Intranasal delivery of nanomicelle curcumin promotes corneal epithelial wound healing in streptozotocin-induced diabetic mice[J]. Sci Rep, 2016, 6: 29753.
46、He J, Pham TL, Kakazu A, et al. Recovery of corneal sensitivity and increase in nerve density and wound healing in diabetic mice after PEDF plus DHA treatment[J]. Diabetes, 2017, 66(9): 2511-2520.He J, Pham TL, Kakazu A, et al. Recovery of corneal sensitivity and increase in nerve density and wound healing in diabetic mice after PEDF plus DHA treatment[J]. Diabetes, 2017, 66(9): 2511-2520.
47、Ljubimov AV, Saghizadeh M. Progress in corneal wound healing[J]. Prog Retin Eye Res, 2015, 49: 17-45.Ljubimov AV, Saghizadeh M. Progress in corneal wound healing[J]. Prog Retin Eye Res, 2015, 49: 17-45.
48、Winkler MA, Dib C, Ljubimov AV, et al. Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas[J]. PLoS One, 2014, 9(12): e114692.Winkler MA, Dib C, Ljubimov AV, et al. Targeting miR-146a to treat delayed wound healing in human diabetic organ-cultured corneas[J]. PLoS One, 2014, 9(12): e114692.
